The experience of the multidisciplinary team in epilepsy management from a resource‐limited country

OBJECTIVE: The use of multidisciplinary teams (MDTs) is a global trend in disease management, while China is still at the exploratory stage MDTs. We aimed to summarize our experience and assess the impact of MDT use in managing patients with epilepsy and optimizing their seizure outcomes. METHODS: Our MDT is staffed with skilled epileptologists, electroencephalography experts, neurosurgeons, child neurologists, radiologists, and psychiatrists. The MDT discussion has been carried out once or twice a week since 2013. We reviewed our consecutive patients discussed at our MDT from March 2013 to December 2017. The detailed clinical characteristics, suggestions, and follow‐up data were collected and analyzed. RESULTS: A total of 1088 patients (604 male, 484 female) were included in this study. The median age at MDT discussion was 21 years (range 10 months to 79 years). Three hundred eighty‐seven patients (35.6%) were younger than18 years of age. The median age at seizure onset was 12 years (range 2 days to 77 years). Most patients (80.4%) had at least one seizure per month and most (77%) took 2 or more antiepileptic drugs. A total of 70.6% of patients reached the standard of drug‐resistant epilepsy and 74.2% of brain magnetic resonance imaging (MRI) studies detected positive findings. After detailed MDT discussion, 18 patients were diagnosed as having nonepileptic diseases, including psychogenic nonepileptic seizure, syncope, sleep disorder, paroxysmal kinesigenic dyskinesia, withdrawal symptom, and cerebral palsy. Three hundred eighty‐two patients (35.1%) were suitable for resective surgery. Among the postoperative patients successfully followed up for more than 1 year, 72.7% (136/187) received favorable outcomes (Engel class I). The seizure‐free rate was 78.6% after temporal lobe surgery and 58.9% after extratemporal surgery. SIGNIFICANCE: Epilepsy management can be optimized through MDT discussion to attain accurate diagnosis and favorable seizure outcomes. There is still room for MDT improvement in resource‐limited countries.